Orbimed Advisors LLC Sarepta Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

$4.15 Billion
Q2 2024

A detailed history of Orbimed Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 646,000 shares of SRPT stock, worth $80.4 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares

646,000

Previous 697,500 7.38%

Holding current value

$80.4 Million

Previous $90.3 Million 13.03%

% of portfolio

2.46%

Previous 2.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $5.84 Million - $8.44 Million	-51,500 Reduced 7.38%	646,000 $102 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $11.3 Million - $21 Million	168,300 Added 31.8%	697,500 $67.3 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $12.8 Million - $15.4 Million	-124,800 Reduced 19.08%	529,200 $64.1 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $22.5 Million - $33.2 Million	-211,100 Reduced 24.4%	654,000 $74.9 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $12.6 Million - $16.7 Million	-107,200 Reduced 11.03%	865,100 $119 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $5.43 Million - $7.11 Million	53,800 Added 5.86%	972,300 $126 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $68 Million - $107 Million	898,500 Added 4492.5%	918,500 $102 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $1.2 Million - $1.69 Million	-19,100 Reduced 48.85%	20,000 $1.5 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $1.24 Million - $1.77 Million	-19,600 Reduced 33.39%	39,100 $3.05 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $463,680 - $596,520	-6,000 Reduced 9.27%	58,700 $5.29 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $9.41 Million - $11.8 Million	-135,578 Reduced 67.69%	64,700 $5.03 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $24.5 Million - $57.2 Million	-338,771 Reduced 62.85%	200,278 $14.9 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $2.62 Million - $3.55 Million	-20,600 Reduced 3.68%	539,049 $75.7 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $31.9 Million - $58.9 Million	-342,800 Reduced 37.99%	559,649 $89.7 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $11.2 Million - $18 Million	136,400 Added 17.81%	902,449 $88.3 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $5.46 Million - $9.67 Million	-71,300 Reduced 8.51%	766,049 $98.9 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $651,576 - $1.4 Million	8,949 Added 1.08%	837,349 $63.1 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $5.06 Million - $7.19 Million	47,400 Added 6.07%	828,400 $98.7 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $7.14 Million - $10.9 Million	-73,400 Reduced 8.59%	781,000 $85.2 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $46.3 Million - $64.9 Million	401,800 Added 88.78%	854,400 $138 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $9.4 Million - $20.1 Million	131,000 Added 40.73%	452,600 $59.8 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $12 Million - $18.3 Million	222,200 Added 223.54%	321,600 $23.8 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $4.74 Million - $5.64 Million	99,400	99,400 $5.53 Million

Others Institutions Holding SRPT

# of Institutions

561

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Sarepta Therapeutics, Inc. Transaction History